Occudo Quantitative Strategies LP Pacira Bio Sciences, Inc. Transaction History

Occudo Quantitative Strategies LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$38.19 - $57.45 $1.8 Million - $2.7 Million	47,037 Added 972.44%	51,874 $2 Million
Q3 2022 Nov 14, 2022	BUY	$51.24 - $58.89 $247,847 - $284,850	4,837 New	4,837 $257,000
Q2 2022 Aug 15, 2022	SELL	$51.49 - $81.64 $303,893 - $481,839	-5,902 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$60.03 - $76.49 $99,829 - $127,202	-1,663 Reduced 21.98%	5,902 $450,000
Q4 2021 Feb 14, 2022	SELL	$47.97 - $62.21 $362,605 - $470,245	-7,559 Reduced 49.98%	7,565 $455,000
Q3 2021 Nov 15, 2021	BUY	$54.64 - $61.3 $186,650 - $209,400	3,416 Added 29.18%	15,124 $847,000
Q2 2021 Aug 16, 2021	BUY	$59.18 - $69.99 $692,879 - $819,442	11,708 New	11,708 $710,000

260

49.8M

1.03M

139K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.1B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.